TNFRSF10B and neoplasm: A study by Huet et al. showed that a pentavalent Nb agonist to death receptor 5 was able to induce greater levels of tumor cell apoptosis than a tetravalent Nb in vitro, and exhibited a greater anti-tumor effect than a death receptor 5 mAb in vivo [129].